VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice

BACKGROUND: Patients with chronic mucocutaneous candidiasis (CMC) often develop azole-resistant Candida infections, making treatment difficult due to lack of oral antifungal drug options. VT-1598 is a novel broad-spectrum fungal CYP51 inhibitor designed for exquisite selectivity for the fungal targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Break, Timothy J, Desai, Jigar V, Natarajan, Mukil, Ferre, Elise, Henderson, Christina, Zelazny, Adrian M, Yates, Christopher M, Cohen, Oren J, Schotzinger, Robert J, Garvey, Edward P, Lionakis, Michail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632136/
http://dx.doi.org/10.1093/ofid/ofx163.132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632136/
http://dx.doi.org/10.1093/ofid/ofx163.132

Ejemplares similares